PUBMED FOR HANDHELDS

Journal Abstract Search


867 related items for PubMed ID: 17085378

  • 1. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 2. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S, Mercuri A, Zucchelli GC, Vassalle C.
    Int J Cardiol; 2006 Feb 15; 107(2):194-9. PubMed ID: 16412796
    [Abstract] [Full Text] [Related]

  • 3. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
    Czarnecka D, Kawecka-Jaszcz K, Olszanecka A, Dembińska-Kieć A, Malczewska-Malec M, Zdzienicka A, Guevara I.
    Med Sci Monit; 2004 Feb 15; 10(2):CR55-61. PubMed ID: 14737044
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N.
    Menopause; 2003 Feb 15; 10(4):286-91. PubMed ID: 12851511
    [Abstract] [Full Text] [Related]

  • 5. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J.
    Przegl Lek; 2007 Feb 15; 64(2):65-9. PubMed ID: 17892034
    [Abstract] [Full Text] [Related]

  • 6. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 15; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 7. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C, Dinçer Cengiz S, Cengiz B, Akgün G.
    Climacteric; 2006 Dec 15; 9(6):437-45. PubMed ID: 17085376
    [Abstract] [Full Text] [Related]

  • 8. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep 15; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC.
    Obstet Gynecol; 1994 Aug 15; 84(2):222-6. PubMed ID: 8041534
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C, Cengiz SD, Cengiz B, Akgun G.
    Gynecol Endocrinol; 2007 Oct 15; 23 Suppl 1():62-7. PubMed ID: 17943541
    [Abstract] [Full Text] [Related]

  • 11. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Oct 15; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 12. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
    Maffei S, Del Ry S, Prontera C, Clerico A.
    Clin Sci (Lond); 2001 Nov 15; 101(5):447-53. PubMed ID: 11672449
    [Abstract] [Full Text] [Related]

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 15; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 14. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
    Alfonso Cano C, Vez García MD, García Urruticoechea P, Tornel Osorio PL, Canteras Jordana M, Abellán Alemán J.
    An Med Interna; 2003 Feb 15; 20(2):70-4. PubMed ID: 12703158
    [Abstract] [Full Text] [Related]

  • 15. 1 and 2 mg 17beta-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women.
    Stevenson JC, Rioux JE, Komer L, Gelfand M.
    Climacteric; 2005 Dec 15; 8(4):352-9. PubMed ID: 16390770
    [Abstract] [Full Text] [Related]

  • 16. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J, Travica S, Metka M, Pietschmann P.
    Wien Klin Wochenschr; 1999 Dec 23; 111(24):1035-43. PubMed ID: 10677891
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy: one-year follow up of DNA damage.
    Casella M, Manfredi S, Andreassi MG, Vassalle C, Prontera C, Simi S, Maffei S.
    Mutat Res; 2005 Aug 01; 585(1-2):14-20. PubMed ID: 15996896
    [Abstract] [Full Text] [Related]

  • 18. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul 01; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 19. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 01; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 20. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul 01; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.